Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Venous thromboembolism: a role for weight-stratified thromboprophylaxis?

Balaji A, Mercer R, Mainwaring J.

Clin Med (Lond). 2015 Dec;15(6):598-9. doi: 10.7861/clinmedicine.15-6-598a. Review. No abstract available.

2.

Venous thromboembolism prevention in medical patients: a framework for improving practice.

Vaughan-Shaw PG, Cannon C.

Phlebology. 2011 Mar;26(2):62-8. doi: 10.1258/phleb.2010.010003. Epub 2011 Jan 12.

PMID:
21228357
3.

Unanswered questions about VTE prophylaxis in critically ill obese patients.

Antigua AD, Voils SA.

Intensive Care Med. 2016 Sep;42(9):1506-7. doi: 10.1007/s00134-016-4431-3. Epub 2016 Jul 13. No abstract available.

PMID:
27412435
4.

Thromboprophylaxis prescribing among junior doctors: the impact of educational interventions.

Watt BJ, Williams DT, Lewis L, Whitaker CJ.

BMC Health Serv Res. 2016 Jul 15;16:267. doi: 10.1186/s12913-016-1480-9.

5.

Implications of thromboprophylaxis registry data on clinical practice.

Caprini JA.

Am J Med Sci. 2009 Jul;338(1):58-63. doi: 10.1097/MAJ.0b013e31819e372d. Review.

PMID:
19474655
6.

Venous Thrombo-Embolic Prophylaxis in Aesthetic Surgery: A National Audit of Practices in the United Kingdom.

Patel L, Gupta RD.

Aesthet Surg J. 2018 May 15;38(6):NP88-NP91. doi: 10.1093/asj/sjy007. No abstract available.

PMID:
29538648
7.

Venous thromboembolism prophylaxis in ENT surgery: a survey of current practice.

Nash R, Randhawa N, Saeed SR.

J Laryngol Otol. 2015 Feb;129(2):164-7. doi: 10.1017/S0022215114003405. Epub 2015 Jan 23.

PMID:
25612642
8.

Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.

Sam JJ, Bernstein CN, Razik R, Thanabalan R, Nguyen GC.

Dig Dis Sci. 2013 Jan;58(1):46-52. doi: 10.1007/s10620-012-2435-6. Epub 2012 Oct 7.

PMID:
23053902
9.

Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists' intervention study.

Khalili H, Dashti-Khavidaki S, Talasaz AH, Mahmoudi L, Eslami K, Tabeefar H.

Pharm World Sci. 2010 Oct;32(5):594-600. doi: 10.1007/s11096-010-9412-y. Epub 2010 Jul 13.

PMID:
20623385
10.

Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members.

Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A.

J Urol. 2013 Sep;190(3):992-8. doi: 10.1016/j.juro.2013.03.076. Epub 2013 Mar 26.

PMID:
23538239
11.

Venous thromboembolism prophylaxis in plastic surgery: a survey of the practice in Denmark.

Nielsen LJ, Matzen SH.

J Plast Surg Hand Surg. 2017 Apr;51(2):122-128. doi: 10.1080/2000656X.2016.1195745. Epub 2016 Jun 16.

PMID:
27310150
12.

Randomized trial of physician alerts for thromboprophylaxis after discharge.

Piazza G, Anderson FA, Ortel TL, Cox MJ, Rosenberg DJ, Rahimian S, Pendergast WJ, McLaren GD, Welker JA, Akus JJ, Stevens SM, Elliott CG, Freeman AL, Patton WF, Dabbagh O, Wyman A, Huang W, Rao AF, Goldhaber SZ.

Am J Med. 2013 May;126(5):435-42. doi: 10.1016/j.amjmed.2012.09.020. Epub 2013 Mar 16.

PMID:
23510945
13.

Venous thromboembolism prophylaxis during and following caesarean section: a survey of clinical practice.

Seeho SK, Nippita TA, Roberts CL, Morris JM, Nassar N.

Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):54-9. doi: 10.1111/ajo.12393. Epub 2015 Aug 21.

PMID:
26293711
14.

Practice Patterns for Prophylaxis and Treatment of Venous Thromboembolism in German Cancer Patients.

Matzdorff A, Ledig B, Stuecker M, Riess H.

Oncol Res Treat. 2016;39(4):194-201. doi: 10.1159/000444734. Epub 2016 Mar 17.

PMID:
27160305
15.

Venous thromboembolism prophylaxis in acute medical admissions to a university teaching hospital.

Lyons O, Loh J, Lim M, O'Riordan D, Silke B.

Ir Med J. 2013 Sep;106(8):235-8.

PMID:
24282892
16.

[Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].

Gouin-Thibault I, Liard F, Van-Ganse E, Vespa L, Gaudin AF, Nachit-Ouinekh F.

Presse Med. 2011 Sep;40(9 Pt 1):e365-75. doi: 10.1016/j.lpm.2010.12.015. Epub 2011 Apr 22. French.

PMID:
21515025
17.

Chest physicians' knowledge of appropriate thromboprophylaxis: insights from the PROMOTE study.

Bikdeli B, Sharif-Kashani B, Raeissi S, Ehteshami-Afshar S, Behzadnia N, Masjedi MR.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):667-72. doi: 10.1097/MBC.0b013e32834ad76d.

PMID:
21986466
18.

Thromboprophylaxis adherence to the ninth edition of American college of chest physicians antithrombotic guidelines in a tertiary care centre: a cross-sectional study.

Thériault T, Touchette M, Goupil V, Echenberg D, Lanthier L.

J Eval Clin Pract. 2016 Dec;22(6):952-957. doi: 10.1111/jep.12569. Epub 2016 Jun 5.

PMID:
27265818
19.

The role of clinically significant venous thromboembolism and thromboprophylaxis in pediatric patients with pelvic or femoral fractures.

Greenwald LJ, Yost MT, Sponseller PD, Abdullah F, Ziegfeld SM, Ain MC.

J Pediatr Orthop. 2012 Jun;32(4):357-61. doi: 10.1097/BPO.0b013e31824b2a07.

PMID:
22584835
20.

Recent pharmacological advances for treating venous thromboembolism: are we witnessing the demise of warfarin?

Kumar S, Howell J, Mattock C.

J R Soc Med. 2013 Nov;106(11):441-6. doi: 10.1177/0141076813498232. Epub 2013 Sep 11. Review.

Supplemental Content

Support Center